MSCV-IRES-Tomato MEF2C Citations (1)
Originally described in: MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallee VP, Hebert J, Krivtsov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A Cancer Discov. 2018 Apr;8(4):478-497. doi: 10.1158/2159-8290.CD-17-1271. Epub 2018 Feb 5. PubMed Journal
Articles Citing MSCV-IRES-Tomato MEF2C
| Articles |
|---|
| 5' Transgenes drive leaky expression of 3' transgenes in Cre-inducible bi-cistronic vectors. Osanai Y, Xing YL, Mochizuki S, Kobayashi K, Homman-Ludiye J, Cooray A, Poh J, Inutsuka A, Ohno N, Merson TD. Mol Ther Methods Clin Dev. 2024 Jun 24;32(3):101288. doi: 10.1016/j.omtm.2024.101288. eCollection 2024 Sep 12. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.